SIBN

SI-BONE, Inc. (NASDAQ:SIBN) is a medical device company founded in 2008 and headquartered in Santa Clara, California. The company went public in October 2018 and specializes in developing and commercializing implantable devices that address musculoskeletal disorders of the sacropelvic anatomy. What began as a single-product company focused on sacroiliac joint dysfunction has evolved into a multi-modality medical device platform targeting various conditions affecting the sacropelvic region, including adult spinal deformity, pelvic trauma, and related orthopedic conditions.